Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.11 AUD | +0.51% | -3.21% | -10.45% |
May. 17 | Australia shares retreat as banks, technology, healthcare stocks drag | RE |
May. 16 | Australia shares jump as US inflation data reinforces rate-cut hopes | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- The firm trades with high earnings multiples: 19.99 times its 2024 earnings per share.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.45% | 7.16B | A- | ||
-23.39% | 15.56B | B+ | ||
-2.70% | 11.65B | B | ||
+2.65% | 11.58B | B+ | ||
+2.37% | 10.06B | B+ | ||
+8.05% | 6.85B | B- | ||
-4.29% | 5.71B | D | ||
+13.33% | 4.3B | B+ | ||
-3.96% | 4.3B | - | ||
-11.58% | 3.9B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RHC Stock
- Ratings Ramsay Health Care Limited